Introduction {#section1-2324709620950128}
============

The number of *Ehrlichia* cases due to *Ehrlichia chaffeensis* reported to the Centers for Disease Control and Prevention (CDC) has increased steadily since the first year of disease reporting. In the year 2000, only 200 cases of ehrlichiosis were reported, while in 2018, 1799 cases were reported by the CDC.

Ehrlichiosis is the general name used to describe diseases caused by the bacteria *E chaffeensis, E ewingii*, or *E muris eauclairensis* in the United States. The majority of reported cases are due to infection by *E chaffeensi*s as per the CDC. Ehrlichiosis used to be known as human monocyte ehlrichisosis, but this term is no longer used. Human disease due to *Ehrlichia* was only recognized in the late 1980s as per the CDC. Since then more number of cases and different clinical manifestations are being reported.

Ehrlichiosis can present with a varied clinical picture. Early signs and symptoms, usually within the first week of the tick bite, include fever, headaches, muscle aches, and rash. As per the CDC, about 1 in 3 people with ehrlichiosis present with a rash, although it may be more common in children. The highest reported rates of ehlrichiosis include Mississippi, Oklahoma, Tennessee, and Arkansas.^[@bibr1-2324709620950128],[@bibr2-2324709620950128]^

Case {#section2-2324709620950128}
====

A 46-year-old Caucasian male from Arkansas with a past medical history of multiple sclerosis, plaque psoriasis presented with generalized weakness of 1 week duration. He also had associated fever and chills for the past day. He did admit to multiple tick bites (2 days ago) from recent travel in Arkansas prior to the symptoms starting. He does not know the duration of tick attachment and did not notice any engorged ticks on removal. On examination, he had a fever of 100.5 °F and a heart rate of 70 beats per minute that was irregularly irregular. Significant laboratory values include a white blood cell count of 4200/µL with 77% neutrophils, platelets of 83 000/µL. Sodium was 131 mEq/L. His BUN (blood urea nitrogen) was 12 mg/dL and creatinine was 1.4 mg/dL. Liver enzymes were within normal limits. Electrocardiogram (EKG) obtained showed variable block atrial flutter with heart rate \<100 beats per minute (prior EKG showed normal sinus rhythm; [Figure 1](#fig1-2324709620950128){ref-type="fig"}). The patient was treated empirically with doxycycline, intravenous fluids, and metoprolol tartrate. *E chaffeensis* immunoglobulin M (IgM) Ab was positive with titers \>1:40 consistent with tick-borne illness due to *E Chaffeensis*. The patient's symptoms improved over the next couple of days and eventually discharged. Repeat EKG 1 month later showed normal sinus rhythm ([Figure 2](#fig2-2324709620950128){ref-type="fig"}).

![Electrocardiogram showing variable block atrial flutter.](10.1177_2324709620950128-fig1){#fig1-2324709620950128}

![Electrocardiogram 1 month later showing resolution of atrial flutter.](10.1177_2324709620950128-fig2){#fig2-2324709620950128}

Discussion {#section3-2324709620950128}
==========

*Ehrlichia chaffeensis* is an obligate intracellular bacterium that belongs to the family Anaplasmataceae. The main vector for *E chaffeensis* in the United states and in Arkansas is the lone star tick, *Amblyomma americanum*.^[@bibr3-2324709620950128],[@bibr4-2324709620950128]^ White tailed deer (*Odocoileus virginianus*) are the main reservoirs for the *E chaffeensis* in Arkansas^[@bibr5-2324709620950128]^ and usually remain persistently infected by the bacteria.^[@bibr6-2324709620950128]^

Ehlrichiosis can present with an early- and late-stage disease. The early stage, within a week of the tick bite, presents with symptoms of fever, muscle aches, headache, and rash. The rash of ehrlichiosis is usually described as a red splotch or pinpoint red dots. The classic associated laboratory abnormalities include anemia, leukopenia, thrombocytopenia, and elevated liver enzymes.^[@bibr7-2324709620950128],[@bibr8-2324709620950128]^ In the late stage of the disease, usually after 2 to 3 weeks of illness, patients can present with severe disease manifested as acute respiratory distress syndrome, meningoencephalitis, seizures, and multi-organ failure.^[@bibr8-2324709620950128]^ Early antibiotics use significantly reduces the risk of progression to severe disease state.^[@bibr8-2324709620950128]^

The diagnosis of *E chaffeensis* is usually made based on the history of a tick bite or exposure to an area with ticks known to cause ehrlichiosis, the presence of signs and symptoms of infection, and pathognomonic laboratory findings. Confirmatory laboratory diagnostic tests include polymerase chain reaction (PCR; sensitivity decreases if done after administration of antibiotics^[@bibr7-2324709620950128]^) and immunofluorescence antibody (IFA) for IgG. The IFA IgG and PCR are collected from serum samples. The IFA IgG is sometimes paired with IgM antibodies, is considered the gold standard, and is the most commonly used confirmatory test.^[@bibr9-2324709620950128]^ As per the CDC, the presence of antibodies, particularly IgM antibodies in the absence of clinical symptoms and signs, reduces the diagnostic value remarkably. The IgG antibody is often negative within the first week of acute illness.^[@bibr3-2324709620950128]^ Negative serological markers does not exclude the diagnosis, especially during an acute illness.^[@bibr3-2324709620950128]^ A single IgG titer of at least 256, seroconversion from negative to positive antibody status (with a minimum titer of 64), and a 4-fold rise in titer during convalescence is highly supportive of the diagnosis ([Table 1](#table1-2324709620950128){ref-type="table"}).^[@bibr10-2324709620950128],[@bibr11-2324709620950128]^

###### 

Timeline of diagnostic laboratory laboratory values in ehlrichiosis.

![](10.1177_2324709620950128-table1)

  --------------------------------------- -------- ------------------
  Early stage (1 week from tick bite)     PCR: +   IgG: − (\<1:16)\
                                                   IgM: −

  Late stage (2-3 weeks from tick bite)   PCR: −   IgG:+ (\>1:256)\
                                                   IgM: +/−
  --------------------------------------- -------- ------------------

Abbreviations: PCR, polymerase chain reaction; Ig, immunoglobulin.

Doxycycline is the drug of choice for treatment of tick-borne illness, usually dosed at 100 mg per os twice a day for a period of 3 to 5 days after symptoms of acute illness of fever have resolved.^[@bibr9-2324709620950128]^ For those with central nervous system involvement, a longer duration of treatment of 10 to 14 days is recommended.^[@bibr9-2324709620950128]^

Tick-borne illness including *E chaffeensis* is a primarily diagnosis based on history and clinical and laboratory findings, which may be confirmed by PCR, IFA-IgG, and IgM. Although the classic clinical presentation is well known, this illness can present atypically as in this patient who presented with atrial flutter in the setting of acute tick-borne illness. The incidence of tick-borne illness due *to E chaffeensis* is on the rise. Atypical and novel presentations of the illness continue to be reported.

Ehrlichiosis affecting the cardiovascular system is rare. Some of the cardiovascular manifestations due to ehlrichiosis that have been reported based on our literature search are listed in [Table 2](#table2-2324709620950128){ref-type="table"}.

###### 

Case reports on cardiac manifestations due to ehrlichiosis.

![](10.1177_2324709620950128-table2)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case records of the Massachusetts General Hospital: A 76-year-old man with fever, dyspnea, pulmonary infiltrates, pleural effusion, and confusion.^[@bibr12-2324709620950128]^   A 76-year-old man from Nantucket, MA, presented with atrial fibrillation and increasing dyspnea found to have bilateral pleural effusions and pulmonary infiltrates. He had normal white blood cell count, thrombocytopenia, and elevated AST and ALT. His hospital course was complicated by him developing confusion, atrial flutter, and found to have ehrlichiosis.
  Ehrlichiosis-induced aseptic meningitis and second-degree heart block in an adolescent male.^[@bibr13-2324709620950128]^                                                         Previously healthy 16-year-old male who presented with acute-onset fatigue, headache, weakness, myalgia, and fevers. He had leukopenia, thrombocytopenia, hyponatremia, and mildly elevated AST. His EKG showed Mobitz Type 1 second-degree heart block and lumbar puncture showed aseptic meningitis. He was found to have ehlrichiosis that was confirmed by PCR.
  Sinus bradycardia: can we blame ehrlichiosis?^[@bibr14-2324709620950128]^                                                                                                        A 54-year-old woman presented with fever, fatigue, and headache. Significant laboratory values included pancytopenia, elevated AST and ALT. Her EKG showed sinus bradycardia ranging from 30 to 60 beats/minute. Peripheral smear confirmed intracytoplasmic morulae consistent with ehrlichiosis. Bradycardia resolved within 48 hours of initiating treatment.
  From tick bite to heart failure: ehrlichial myocarditis.^[@bibr15-2324709620950128]^                                                                                             A 58-year-old woman presented with confusion, dyspnea, generalized weakness, fever, and a rash. She had pancytopenia, acute kidney injury, and elevated AST. Her chest X-ray showed bilateral diffuse infiltrates. EKG subsequently during hospital course showed diffuse ST changes and elevated troponin. Her cardiac catheterization showed normal coronary angiography. Her *Ehrlichia* PCR was positive. She was also noted to have multiple episodes of nonsustained ventricular tachycardia. Echocardiogram revealed global hypokinesis and an ejection fraction of 30%. Cardiac MRI revealed delayed enhancement in multiple areas of myocardium and pericardium consistent with myopericarditis.
  Fatal ehrlichial myocarditis in a healthy adolescent: a case report and review of the literature.^[@bibr16-2324709620950128]^                                                    Previously healthy 15-year-old girl presented with fever, myalgia, headache, confusion, and a petechial rash. Chest radiograph revealed bibasilar infiltrates. Significant laboratory values included pancytopenia, elevated AST and ALT, and hyponatremia. EKG showed diffuse ST elevation. Her echocardiogram revealed a small pericardial effusion, global hypokinesis with an ejection fraction of 30%. She eventually developed pulseless electrical activity and pulseless ventricular tachycardia that failed to respond to resuscitative efforts. PCR 2 days later confirmed *Ehlrichia*.
  Human ehlrichiosis causing left ventricular dilation and dysfunction.^[@bibr17-2324709620950128]^                                                                                A 27-year-old previously health male presented with malaise, myalgia, fever, headache, nausea, and vomiting. He had leukopenia and thrombocytopenia with mildly elevated AST and ALT. He eventually developed confusion and dyspnea. Chest radiograph showed small pleural effusions and enlarged cardiac silhouette. EKG was normal. Echocardiogram showed a dilated left ventricle, small pericardial effusion, and a normal ejection fraction. He was treated with doxycycline for 10 days with improvement in symptoms. Follow-up echocardiogram on day 16 showed partial resolution of left ventricular dilation. Six weeks after discharge, the patient was entirely well. His *Ehlrichia* antibody titer increased from \<1:16 on day 4 to 1:256 on day 21 consistent with ehrlichiosis.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; EKG, electrocardiogram; PCR, polymerase chain reaction; MRI, magnetic resonance imaging.

In ehrlichiosis, the host systemic inflammatory response rather than direct effects of the pathogen is likely to be largely responsible for many of the clinical manifestations of ehrlichiosis.^[@bibr18-2324709620950128]^ Unlike RMSF (Rocky mountain spotted fever), direct vasculitis and endothelial injury is rare in ehrlichiosis.^[@bibr10-2324709620950128]^ The pathophysiology on how the bacteria cause atrial fibrillation or atrial flutter is unclear, thus warranting further understanding on these mechanisms. With case reports showing evidence of myocarditis and pericarditis related to ehrlichiosis, this could be a potential pathophysiological mechanism for underlying cardiac manifestations related to ehrlichia but more studies would be warranted to confirm the diagnosis.

In Lyme carditis, animal studies in both monkeys and mice have shown that inflammation within heart is seen transmurally, which is predominantly macrophage and lymphocyte infiltrates.^[@bibr19-2324709620950128]^ However in Lyme carditis, atrioventricular conduction block of varying severity was the most common manifestation.^[@bibr20-2324709620950128],[@bibr21-2324709620950128]^

With the number of cases of ehrlichiosis on the rise, this case teaches the clinician another rare cause of new-onset atrial fibrillation and/or flutter could be due to *E chaffeensis*--associated illness. One particular cause of an increasing incidence of tick-borne illness in the southern states of the United States has been attributed to the increasing population of white tailed deer, which serves as a natural reservoir for the bacteria.^[@bibr22-2324709620950128]^ Early identification of the illness based on history, signs and symptoms, and laboratory findings warrants treatment with antibiotics to prevent complications of late illness, which can be severe.

Prevention of tick bites by avoidance and immediate removal of ticks remains the best approach^[@bibr2-2324709620950128]^ for prevention of the illness. Studies have shown the tick requires at least 4 to 24 hours of attachment to transmit the disease and therefore immediate removal is the mainstay of prevention.^[@bibr23-2324709620950128]^ There has been no evidence for preventive antibiotic treatment in those who are not ill.^[@bibr1-2324709620950128]^
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